Wuhu Simcere Zhongren Pharmaceutical

Simcere Zhongren Pharmaceutical, a subsidiary of Simcere Pharmaceutical Group, is a specialized pharmaceutical company based in Wuhu, China, focusing on the development and manufacturing of anti-tumor sustained-release formulations. The company is best known for its flagship product, Sinofuan (Fluorouracil Sustained-release Implants), which is designed for interstitial implantation during surgery to provide localized, long-term chemotherapy. Their technology platform focuses on improving the efficacy and reducing the systemic toxicity of traditional chemotherapeutic agents through innovative drug delivery systems. Simcere Zhongren operates high-standard GMP manufacturing facilities and contributes significantly to Simcere's oncology portfolio.